These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1229 related articles for article (PubMed ID: 32305351)

  • 1. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Extracellular Vesicles Loaded with Therapeutic Cargo.
    Lamichhane TN; Jay SM
    Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
    Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
    Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of targeted extracellular vesicles for drug delivery - Considerations on methodological and biological heterogeneity.
    Gudbergsson JM; Jønsson K; Simonsen JB; Johnsen KB
    J Control Release; 2019 Jul; 306():108-120. PubMed ID: 31175896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles as drug delivery systems: lessons from the liposome field.
    van der Meel R; Fens MH; Vader P; van Solinge WW; Eniola-Adefeso O; Schiffelers RM
    J Control Release; 2014 Dec; 195():72-85. PubMed ID: 25094032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous cancer cell-derived extracellular vesicles as drug-delivery systems: a systematic review of preclinical and clinical findings and translational implications.
    Li YJ; Wu JY; Hu XB; Wang JM; Xiang DX
    Nanomedicine (Lond); 2019 Feb; 14(4):493-509. PubMed ID: 30694095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nature's carriers: leveraging extracellular vesicles for targeted drug delivery.
    Chen Q; Zheng Y; Jiang X; Wang Y; Chen Z; Wu D
    Drug Deliv; 2024 Dec; 31(1):2361165. PubMed ID: 38832506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment.
    Erkan EP; Saydam O
    Curr Cancer Drug Targets; 2016; 16(1):34-42. PubMed ID: 26412464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.